Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5234_Библиотеки_им_академика_М_И_Перельмана
.pdf
Ethical Issues in
5
Neurodisorder Diagnosis
Computational Intelligence
toward Compassionate
Psychiatric Treatment
Bhupinder Singh, Rishabha Malviya,
and Christian Kaunert
5.1 INTRODUCTION
Computational intelligence (CI) advancements raise critical issues affecting privacy and data security. Diagnoses for neurodisorders usually indicate the most
clinically sensitive aspects of a patient’s mental and emotional well-being. Such
advancements have transformed the neurodisorder diagnosis landscape, providing
a new actionable avenue for more precise and individualized psychiatric therapy
[1]. The overreliance on technology at times when humanistic perspectives might
provide appropriate transparency and explainability and elicit informed consent
presents issues constraining these systems, as complexity makes such processes
extremely hard for healthcare providers to communicate to patients fully [2]. As
CI is increasingly adopted in clinical psychiatry, it will be important to balance
the embrace of systems capable of tracking and utilizing mental health information with a frontline stance that humanizes patient care − fostering engagement
and observance while supporting autonomy and shared decision-making between
patients and clinicians based on evidence-based management options, as well as
facilitating active working alliance through psychoeducation targeting diverse
aspects. Such ethical issues should be met for the responsible and ethical use of
CI in neurodisorder diagnosis and therapy [3]. Figure 5.1 depicts the landscapes of
introduction split sections.
5.2 OVERVIEW OF NEURODISORDERS
Neurologial disorders, or neurodisorders, are diseases of the central and peripheral
nervous system [4]. Such disorders manifest with various symptoms, like cogni-
tive impairment, motor decits (ataxia), sensory loss, and emotional disturbances
[5]. Progress in the eld of CI may change a diagnosis and treatment for neurodisorders radically, including machine learning (ML) or articial intelligence
54
DO I: 10.1201/ 97810 03520 34 4 - 6
55 Ethical Issues in Neurodisorder Diagnosis
FIGURE 5.1 The landscapes of introduction split sections. (Source: Original.)
(AI) [6]. It is important to underscore potential ethical considerations associated
with the integration of CI in psychiatric care [7]. Major ethical considerations
include privacy concerns, algorithmic bias, and the risk of technology superseding human-based health practices [8]. As CI increasingly becomes a part of neurodisorder diagnosis and therapy, it is also vital to continue the advocacy for
compassionate healthcare that honors patient autonomy while promoting shared
decision-making [9].
5.3 ROLE OF COMPUTATIONAL INTELLIGENCE IN PSYCHIATRY
Fine-tuning image-based diagnosis and fostering creative treatment strategies for neurodisorders can be signicantly enhanced through the application of Computational
Intelligence, particularly the integration of Machine Learning and Articial
Intelligence techniques [10]. To change the future by improving diagnostic accuracy,
allowing for unique tailored treatment plans and earlier intervention, Machine learning have the potential to help improve not only quality of life but ultimately increase
the lifespan [11]. Yet, the inclusion of CI in mental healthcare provokes much needed
ethical questions too [12]. Ethically, important issue in machine learning include
algorithms bias that can entrench societal biases as well and creation of new discrimination against socially vulnerable populations [13]. It also raises questions about privacy, transparency, and the risk of overutilizing technology without human-centered
care [14]. Overcoming these ethical hurdles is essential if the responsible and humanistic use of CI for diagnosing and treating neurodisorders is to be achieved [15].
5.4 IMPORTANCE OF ETHICAL CONSIDERATIONS
IN NEURODISORDER DIAGNOSIS
Such applications are recommended even for examples of common neurodisorders
(e.g., stroke, Parkinson’s disease, dementia, attention decit hyperactivity disorder
[ADHD], and functional neurological disorder [FND]) [5]. These conditions can signicantly affect an individual’s quality of life and put a heavy nancial weight on
that person, as well as healthcare systems [16]. The increasing role of CO (e.g., ML
56 Computational Intelligence Algorithms
and AI) in the diagnosis, management, conducting of procedures, and treatment of
neurodisorders puts an emphasis on maintaining a compassionate approach to clinical
care that honors patient autonomy while also supporting shared decision-making [17].
Since the technologies are being used for life-threatening situations, it is very important to follow some ethical considerations [18]. Major ethical concerns are related to
privacy, algorithmic bias, and overdigitization taking away the human responsibility
from a part of care [19]. More generally, issues of being transparent and articulate are
present in the description that must be given to patients before their decision concerning how data-hungry this method can get [20].
5.5 UNDERSTANDING NEURODISORDERS: DEFINITION
AND TYPES OF NEURODISORDERS
These are a group of diseases referred to as neurodisorders, specialized conditions
that affect our brain and spinal cord [21]. These range from cognitive through
motor and sensory to emotional disorders. These disorders cover a broad range,
affecting cognitive abilities, motor skills, sensory perception, and emotional wellbeing. More and more, experts are suggesting the use of cutting-edge technologies like AI and machine learning to help manage prevalent neurodisorders such
as stroke, Parkinson’s disease, dementia, ADHD, and Functional Neurological
Disorder (FND) [22]. These conditions can deeply affect a person’s quality of life
and create a hefty nancial strain on both those who are affected and the healthcare system as a whole [23].
5.6 PREVALENCE AND IMPACT ON SOCIETY
Neurodisorders such as stroke, Parkinson’s disease, dementia, and ADHD are
the leading causes of morbidity in some countries and can lead to poor quality
of life and a burden on healthcare systems. This can manifest phenotypically
in cognitive impairment, motor dysfunction, and deficits related to emotional
processing. Gone Integrating CI (i.e., ML and AI) in the diagnosis and treatment
of neurodisorders represents a promising approach to improving care for these
patients [24].
5.7 SPECIFIC ETHICAL ISSUES AND DECISION-MAKING
SCENARIOS IN CLINICAL PSYCHIATRY
Clinical psychiatry is where the ethical dilemma lies in a complexly woven web
of patient autonomy, condentiality, and benecence [25]. Although keeping a
patient’s condential information private is very important, there are circumstances where you might need to share such information with someone else, such
as when a patient says they are going to hurt themselves or others. Psychiatrists
have to appropriately assess the risk and see if breaching condentiality falls
within legal and ethical criteria [26].
57 Ethical Issues in Neurodisorder Diagnosis
5.8 COMPUTATIONAL INTELLIGENCE IN PSYCHIATRIC DIAGNOSIS
CI, including the use of ML and AI to diagnose and treat neurodisorders, has been
widely looked at as an avenue with signicant promise [27]. These technologies can
help boost diagnosis accuracy, support personalized treatments, and promote early
intervention. Psychiatry has very important ethical considerations when using CI to
help treat patients [28].
5.9 APPLICATION OF CI IN DIAGNOSING NEURODISORDERS
There are also concerns over algorithmic bias, whereby the algorithms involved might
reinforce social biases and further disadvantage already marginalized demographics
[30]. The benets of using CI for psychiatric diagnosis is depicted in Figure 5.2.
CI algorithms can learn from the vast amounts of patient data available with neuroimaging, genetics information, and clinical symptoms. It should be very capable
of detecting patterns in such data, resulting in more accurate diagnosis [31]. This can
allow for an earlier and honed treatment of tumors, for example, which may improve
patient outcomes. Incorporation of CI, just like ML and AI in the eld of diagnosis and treatment for neurodisorders, might be a great advancement [32]. These
technologies can increase diagnostic precision, limit a course of treatment to the
patient only, and support earlier intervention. The routine use of CI for psychiatric
FIGURE 5.2 Benets of using CI for psychiatric diagnosis. (Source: Original.)
58 Computational Intelligence Algorithms
diagnosis has the potential to be highly benecial, as these technologies can increase
diagnostic precision, tailor treatment plans to individual patients, and support earlier
intervention [33].
Treatment strategies can be customized. CI can analyze data from individual
patients to build personalized treatment plans that are more likely to reect specic idiosyncrasies of each patient’s condition, thus improving and even shortening treatment. CI algorithms can detect subtle neurodisorder signs and cognitive
symptoms earlier than conventional diagnostic techniques [34]. This enables timely
intervention that is essential in preventing or delaying onset of these disorders [35].
The inuence of prejudices that may affect human judgment in psychiatric diagnosis can be reduced by CI algorithms. This can result in more impartial and repeatable diagnoses [36]. Yet, this implementation of CI in psychiatric care also has
far-reaching ethical implications that deserve closer attention, including privacy
risks, algorithmic bias, and the risk for technology to overpower human-centered
approaches [37].
5.10 ETHICAL ISSUES IN NEURODISORDER DIAGNOSIS USING CI
The integration of CI including ML and AI in the diagnosis and treatment of neurodisorders raises several ethical challenges that need to be discussed, such as privacy,
because CI algorithms usually act upon privacy-related patient data like neuroimaging, genetic, and clinical information [38]. Protecting the privacy and security
of such data are paramount but not at the expense of patients being well informed
about how their data will be used as part of connected care that benets them [8].
To some extent, this is because CI can have the highly desirable effect of increasing
diagnostic accuracy and personalizing treatment, but there are also concerns that
physicians will come to rely on these technologies at the expense of human-centered
care. It must balance harnessing the advantages offered by CI and a compassionate
approach that keeps patient dignity at heart [39]. It is necessary to deal with these
ethical dilemmas in order to ensure that CI is utilized responsibly and compassionately for the diagnosis and management of neurodisorders [40]. Continued collabora-
tion among clinicians, researchers, ethicists, and patients is needed to guide the way
through these knotty problems [41].
5.11 PRIVACY AND DATA SECURITY
Sobering concerns have also been raised in relation to neurodisorder diagnosis via
CI, including ML and AI, which are nevertheless paramount as the process of data
produced by mental processes [42]. Patient data collected and analyzed through these
technologies include neuroimaging, genetics, as well as clinical information that is
sensitive [43]. Maintaining the privacy and security of such data are paramount to
preventing discrimination, stigmatization, and psychological harm for patients [5].
Patients have to completely understand what will be done with their data and how
they are secured, and then their formal agreement reached in a clear manner. Data
security measures like encryption, access controls, and regular security audits while
59 Ethical Issues in Neurodisorder Diagnosis
diagnosing neurodisorders through CI need to be adopted by the healthcare provider
and researchers [44]. They also need to follow strict data governance rules that outline ownership, sharing, and retention dened data [45]. At the same time, in designing CI algorithms for neurodisorder diagnosis, it is necessary to follow privacy by
design principles such as data minimization, purpose limitation, and storage limitation [46]. Remember that this can be a way to make sure that only the data needed
for proper diagnosis and treatment are being collected and preserved. Focusing on
ensuring patient privacy and data protection can help healthcare providers gain public support for CI-assisted neurodisorder diagnosis to benet patients in a safe, ethical way [47].
5.12 BIAS AND FAIRNESS IN CI ALGORITHMS
Important concerns regarding fairness and bias can be brought up by the use of CI
algorithms in the diagnosis of neurological diseases [9]. If these algorithms are not
sufciently built and veried, they could lead to the marginalization of people with
disabilities and perpetuate social prejudices [48]. Several factors, including skewed
training data, incorrect algorithms, or the naturally inherent preconceptions of the
software developers, are susceptible to algorithmic bias. In this case, a CI algorithm
may diagnose neurodisorders with lower precision in specic populations if trained
on data that demographically underrepresent those groups [49]. It is essential to make
sure that CI algorithms are created and evaluated using a variety of representative
datasets in order to reduce the possibility of bias. Throughout the algorithm creation
process, developers should watch for possible biases and take suitable measures to
detect and address them [50].
5.13 TRANSPARENCY AND EXPLAINABILITY
An important ethical component to take into account when applying CI algorithms
for diagnosing neurodisorders is the question of transparency and explainability
[51]. Medical professionals may nd it challenging to properly explain the decision-
making process to patients due to the intricacy of these algorithms, which poses
problems with informed consent [52]. Figure 5.3 species points on transparency
and explainability.
The following are the salient features of the consent−autonomy relationship in
the context of CI-based neurodisorder diagnosis. Informed consent is a means of
safeguarding and promoting patient autonomy by ensuring they are aware of the suggested course of treatment and are able to make an informed choice [53]. Autonomy
is regarded as an individual’s ability to make free and rational choices about their
healthcare. Informed permission is important for protecting patient autonomy when
utilizing CI to diagnose neurodisorders [54]. This empowers patients to make independent decisions about accomplishing the CI-based diagnosing. Patients must have
a complete understanding of how their data will be collected and used, the potential
advantages and perils of the CI-based diagnosis, and any alternatives [55]. It may
be challenging for medical professionals to thoroughly explain the decision-making
process to patients due to the intricacy of CI algorithms employed in the diagnosis
60 Computational Intelligence Algorithms
FIGURE 5.3 Species the points on transparency and explainability. (Source: Original.)
of neurodisorders. In order to support informed consent and collaborative decisionmaking, efforts must be made to improve the explainability and transparency of
these algorithms [56]. Encouraging benecence, or acting in the patient’s best interest, but still respecting their autonomy may conict. In order to give the best care
possible and make sure CI-based diagnoses respect autonomy, healthcare professionals need to carefully oversee this ne line [57].
5.14 CONSENT AND AUTONOMY
Few things are as central when it comes to use of CI for neurodisorder diagnosis
than the matter of autonomy and consent. Autonomy is a patient’s ability to make
free and informed decisions regarding their own care, while informed consent helps
safeguard this autonomy [58]. In the setting of CI-based diagnosis, patients must be
given full disclosure as to how their data are used and may gain benet or risk associated with any alternatives [59]. In this way, they can decide for themselves whether
or not to go forward with the diagnostic process [60]. However, critical parts of
the decision-making capacity may be impaired in some neurodisorder patients; having sound informed consent might become very difcult to achieve [61]. Individual
autonomy must always be weighed against benecence, the moral obligation to act in
a way that benets others. To allow informed consent and shared decision making,
it is important to enhance the transparency and explainability of CI algorithms [62].
5.15 ENSURING INFORMED CONSENT IN CI-BASED DIAGNOSIS
One of the most important ethical issues is reasoning about how to obtain informed
consent when analyzing neurodisease in using CI [63]. Patients need to get clear,
61 Ethical Issues in Neurodisorder Diagnosis
understandable information about the treatment process when using CI data and with
whom and under which conditions this will or can be shared (a privacy statement)
[64]. These individuals should also be informed of possible advantages, risks, and
disadvantages of the technology [65]. The consent process should be continuous,
with the patient having an opportunity to ask questions and withdraw consent at
any time [66]. Providers may also be required to obtain consent from family members or legal guardians for patients with impaired decision-making capacity. Patient
autonomy is paramount, and making well-informed decisions in their care respects
transparency with shared decision-making [67].
5.16 BALANCING AUTOMATION AND PATIENT AUTONOMY
In the future, if it begins to be more common to use CI in neurodisorder diagnosis,
then we may run into a problem of overautomating our diagnostics and taking away
from patient autonomy [68]. However, we should not replace human intervention
and the therapeutic alliance of the patient−provider relationship. Healthcare profes-
sionals need to nd the right balance by taking advantage of CI while concurrently
ensuring patient autonomy and promoting shared decision-making [69]. That could
include, with regard to greater transparency over how the algorithms operate, getting
patients involved in understanding results and keeping humans (clinicians) as part
of the diagnostic process [70]. But the aim, in the end, is to enable patients to have
information with which they can make decisions − not simply give up control so that
automated systems take over [71].
5.17 CONCLUSION AND FUTURE SCOPE SMART
SUSTAINABLE CITIES: A GUIDE TO TECHNOLOGY,
DATA, AND URBAN TRANSFORMATION
The use of CI technologies in smart sustainable city development can provide a
promising solution to promoting urban sustainability and enabling transformative
changes [72]. But it must tread cautiously − while thoughtful application of AI holds
the promise, the potential misuse and responsible use come with signicant ethical
considerations [73]. Ethical considerations include data privacy and security, algorithmic bias, transparency and explainability, and impact on vulnerable population.
To inspire trust and guard against these risks, all AI regulation requires strong data
frameworks combined with machine audit processes that are accompanied by a
society-wide commitment to transparency.
REFERENCES
1. Kim, J., He, M. J., Widmann, A. K., & Lee, F. S. (2024). The role of neurotrophic factors in novel, rapid psychiatric treatments. Neuropsychopharmacology, 49(1), 227–245.
2. Panda, M., Abraham, A., Gopi, B., & Ajith, R. (Eds.). (2024). Computational
Intelligence for Oncology and Neurological Disorders: Current Practices and Future
Directions. CRC Press.
62 Computational Intelligence Algorithms
3. Bhatt, S. (2024). Digital mental health: Role of articial intelligence in psychotherapy.
Annals of Neurosciences. https://doi.org/10.1177/09727531231221612.
4. Singh, B., & Kaunert, C. (2024). Future of digital marketing: Hyper-personalized
customer dynamic experience with AI-based predictive models. In A. Khang, et al.
(Eds.). Revolutionizing the AI-Digital Landscape: A Guide to Sustainable Emerging
Technologies for Marketing Professionals (p. 189–205). CRC Press.
5. Singh, B., Kaunert, C., & Vig, K. (2024). Reinventing inuence of articial intelligence (AI) on digital consumer lensing transforming consumer recommendation
model: Exploring stimulus articial intelligence on consumer shopping decisions.
In T. Musiolik, R. Rodriguez, & H. Kannan (Eds.), AI Impacts in Digital Consumer
Behavior (pp. 141–169). IGI Global. https://doi.org/10.4018/979-8-3693-1918-5.
ch006
6. Chatterjee, J. M., & Saxena, S. K. (Eds.). (2023). Articial Intelligence in Medical
Virology. Springer Nature.
7. Mohammadi, A. T., Far, Y. K., Ghaemi, Z., Kamran, Z., Andalibian, M., Farhanian,
A., … & Mir, A. (2023). Neuroscience and Technology: Innovations in Brain Research
and Therapy. Nobel Sciences.
8. Singh, B., & Kaunert, C. (2024). Salvaging responsible consumption and production
of food in the hospitality industry: Harnessing machine learning and deep learning for
zero food waste. In A. Singh, P. Tyagi, & A. Garg (Eds.), Sustainable Disposal Methods
of Food Wastes in Hospitality Operations (pp. 176–192). IGI Global.
9. Singh, B. (2024). Evolutionary global neuroscience for cognition and brain health:
Strengthening innovation in brain science. In P. Prabhakar (Ed.), Biomedical Research
Developments for Improved Healthcare (pp. 246–272). IGI Global.
10. Swargiary, K., & Roy, K. (2024). AI Angels: Empowering Children with Special Needs
through Articial Intelligence. Scholar press.
11. Chiaravalloti, M. T., Taverniti, M., & Dovetto, F. M. (2023, December). Preserving
cultural heritage: digitizing the historical archive of the former psychiatric Hospital
of girifalco (South Italy). In 2023 7th IEEE Congress on Information Science and
Technology (CiSt) (pp. 627–633). IEEE.
12. Zadoo, S., Singh, Y., & Singh, P. K. (2024). Automated Parkinson’s disease detection: A review of techniques, datasets, modalities, and open challenges. International
Journal on Smart Sensing and Intelligent Systems, 17(1).
13. Rotenberg, A. (2023). The neurotechnology patent landscape in a time of neuroethics:
2016–2020 (Doctoral dissertation, University of British Columbia).
14. Sarkar, S., Singh, Y. C., & Kaloiya, G. S. (2024). Psychotherapy and psychotropic
drug treatment: neurobiological and psychodynamic perspectives. Indian Journal of
Psychiatry, 66, S126.
15. Sokolova, A., Lobanova, P., & Kuzminov, I. (2024). Identifying emerging trends and
hot topics through intelligent data mining: The case of clinical psychology and psychotherap y. Foresight, 26(1), 155 –180.
16. Singh, B., & Kaunert, C. (2024). Revealing green nance mobilization: Harnessing
FinTech and blockchain innovations to surmount barriers and foster new investment
avenues. In S. H. Jafar, R. V. Rodriguez, H. Kannan, S. Akhtar, & P. Plugmann (Eds.),
Harnessing B lockchain-D igital Twin Fusion for Sus tainable Investme nts (pp. 265–286).
IGI Global.
17. Utting, A. L. (2023). The Role of Compassion in the Psychological Impact of Functional
Seizures (Doctoral dissertation, University of Hull).
18. Hyland, T. (2023). Consciousness, Neo-Idealism and the Myth of Mental Illness. Qeios.
https://doi.org/10.32388/NQPQ7S
19. Kakum anu, S. A., Srija, P., Sai Ha rshitha, K. K., Abinay, M., & Ak hil, K. (2023, October).
A semantic web-based prototype exercise—video game for children with anxiety and
63 Ethical Issues in Neurodisorder Diagnosis
juvenile myoclonic epilepsy and its usability assessment. In International Conference
on Trends in Sustainable Computing and Machine Intelligence (pp. 155–167).
Singapore: Springer Nature Singapore.
20. Singh, B. (2024). Featuring consumer choices of consumable products for health benets: Evolving issues from tort and product liabilities. Journal of Law of Torts and
Consumer Protection Law, 7(1), 53–56.
21. Singh, B. (2024). Social cognition of incarcerated women and children: Addressing
exposure to infectious diseases and legal outcomes. In K. Reddy (Ed.), Principles
and Clinical Interventions in Social Cognition (pp. 236–251). IGI Global. https://doi.
org/10.4018/979-8-3693-1265-0.ch014
22. Singh, B., & Kaunert, C. (2024). Harnessing sustainable agriculture through climatesmart technologies: Articial intelligence for climate preservation and futuristic trends.
In H. Kannan, R. V. Rodriguez, Z. Z. Paprika, & A. Ade-Ibijola (Eds.), Exploring
Ethical Dimensions of Environmental Sustainability and Use of AI (pp. 214 –239).
IGI Global.
23. Reuber, M., McCormick, M., Rawlings, G. H., & Stone, J. (Eds.). (2024). FND Stories:
Personal and Professional Experiences of Functional Neurological Disorder. Jessica
Kingsley Publishers.
24. Banazadeh, M., Abiri, A., Poortaheri, M. M., Asnaashari, L., Langarizadeh,
M. A., & Forootanfar, H. (2024). Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review. International Journal of Biological Macromolecules,
130413.
25. Upadhyay, S. K., Dan, S., & Ali, S. A. (2024). Evidence-Based Neurological Disorders:
Symptoms, Causes, and Therapy. CRC Press.
26. Singh, B. (2023). Unleashing alternative dispute Resolution (ADR) in resolving complex legal-technical issues arising in cyberspace lensing e-commerce and intellectual property: Proliferation of e-commerce digital economy. Revista Brasileira de
Alternative Dispute Resolution-Brazilian Journal of Alternative Dispute ResolutionRBADR, 5(10), 81–105.
27. Singh, B., & Kaunert, C. (2024). Integration of cutting-edge technologies such as internet of things (IoT) and 5G in health monitoring systems: A comprehensive legal analysis and futuristic outcomes. GLS Law Journal, 6(1), 13 –20.
28. Martinez, C. I., Liktor-Busa, E., & Largent-Milnes, T. M. (2024). Problems in management of medication overuse headache in transgender and gender non-conforming
populations. Frontiers in Neurology, 15, 1320791.
29. Singh, B. (2023). Blockchain technology in renovating healthcare: Legal and future perspectives. In Revolutionizing Healthcare Through Articial Intelligence and Internet
of Things Applications (pp. 177–186). IGI Global.
30. Singh, B. (2023). Federated learning for envision future trajectory smart transport system for climate preservation and smart green planet: Insights into global governance and
SDG-9 (Industry, innovation and infrastructure). National Journal of Environmental
Law, 6(2), 6 –17.
31. Damm, J. (2023). How Do Mental Health Professionals Provide Therapy to Couples in
Neurodiverse Relationships: A Constructivist Grounded Theory Study (Doctoral dissertation, Washington State University).
32. FREUD’S, E. A. (2024). Oral (including PIF and Rapid Fire). Australian & New
Zealand, 58, 122.
33. Hartley, M. R. (2023). Mindfulness-Based Interventions for Individuals with Autism
Spectrum Disorder and Their Caregivers (Doctoral dissertation).
34. Chambers, E. V. (2024). Strategies Managers Use to Integrate Autistic Employees
Into a Diverse Workforce (Doctoral dissertation, Walden University). Retrieved from
https://scholarworks.waldenu.edu/dissertations/15385/
Соседние файлы в папке Библиотека им академика М.И. Перельмана